Skip to main content
NIH funding notice PAR-21-056

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)

Closed on September 7, 2023.

Posted
November 19, 2020
Close date
September 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,444,308 in first-year total cost, median $1,444,308.

Most frequent study sections

  1. Neurological Sciences and Disorders A Study Section[NSD-A]1

Most frequent institutions

  1. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
Competing awards under PAR-21-056 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Analytical characterization and validation of blood-biomarkers for monitoring TBI evolution1U01NS131740-01A1DIAZ-ARRASTIA, RAMONHUTCHISON, JAMIE SANDERSMONDELLO, STEFANIAPUCCIO, AVA M.WANG, KEVIN KA WANGWELLINGTON, CHERYL LEAUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$1,444,308NSD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.